Andrew Horowitz

Andy Horowitz is the founder and CEO of Enclara Pharmacia. An attorney by education, he transitioned into healthcare to become a highly regarded and successful pharmaceutical and healthcare entrepreneur and leader.

Andy founded Partners Healthcare, which focused on the institutional long-term care market, and Solutions Homecare, a JCAHO-accredited infusion therapy company. He acquired the hospice business known as Garden State Hospice and, after rebranding it Care Alternatives, developed it into a large, regional hospice services company providing care to approximately 800 ADC. Between 1998 and 2004, Andy grew these companies into one of the largest privately held institutional pharmacies and hospices in the country, serving six states until he sold the companies in 2004.

He founded Enclara Health in 2006, a national hospice-specialty pharmacy services provider, moving the company from a start-up enterprise toward significant growth driven by differentiated service-oriented product offerings.

In 2013, Andy founded Turn-Key Health, an affiliate of Enclara, that is grounded in clinical and financial models that are designed to address the avoidable $20 billion spend on excessive, suboptimal care. Turn-Key is a population health management company serving health plans, provider organizations and their members who are experiencing a serious or advanced illness. Its unique community-based model, Palliative Illness Management™ (PIM™), identifies, engages, and improves the member and caregiver quality of life.

In 2014, he partnered with Consonance Capital Partners to purchase excelleRx/Hospice Pharmacia, merging Enclara Health and Hospice Pharmacia to create Enclara Pharmacia, the premier hospice pharmacy benefits management (PBM) provider with comprehensive services for medication access, innovative technology solutions, and clinical excellence.

In the same year, Andy also acquired PBM Plus to create GuidantRx, a boutique pharmacy benefit management provider specializing in co-pay card services and specialty pharmacy workflows.